Castle Biosciences (CSTL) Debt to Equity (2017 - 2026)
Castle Biosciences (CSTL) debt to equity from Dec 31, 2017 to Mar 31, 2026. The current Castle Biosciences (CSTL) debt to equity is 2.18%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Debt to Equity
Debt to Equity
Annual Debt to Equity change of Castle Biosciences (CSTL)
| Year | Debt to Equity | Change |
|---|---|---|
| 2025 | 2.14% | -2.81% |
| 2024 | 2.20% | N/A |
| 2023 | 0.00% | N/A |
| 2022 | 0.00% | N/A |
| 2021 | 0.00% | N/A |
| 2020 | 0.00% | -100.00% |
| 2019 | 29.51% | -168.15% |
| 2018 | -43.31% | N/A |
| 2017 | 0.00% | N/A |
Comparison Castle Biosciences (CSTL) debt to equity with competitors
Castle Biosciences (CSTL) debt to equity is 2.18%.